Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0.96)
# 3,889
Out of 5,015 analysts
326
Total ratings
26.22%
Success rate
-20.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Assumes: Buy | $60 | $33.76 | +77.73% | 1 | Oct 6, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $38 → $59 | $31.37 | +88.08% | 11 | Sep 30, 2025 | |
| IOBT IO Biotech | Downgrades: Neutral | n/a | $0.55 | - | 14 | Sep 29, 2025 | |
| AGEN Agenus | Reiterates: Buy | $23 | $3.97 | +479.35% | 20 | Sep 10, 2025 | |
| AGIO Agios Pharmaceuticals | Reiterates: Buy | $56 | $40.61 | +37.90% | 2 | Sep 4, 2025 | |
| BCTX BriaCell Therapeutics | Maintains: Buy | $32 → $40 | $12.40 | +222.58% | 15 | Aug 27, 2025 | |
| INKT MiNK Therapeutics | Upgrades: Buy | $35 | $14.00 | +150.00% | 14 | Aug 15, 2025 | |
| VTVT vTv Therapeutics | Reiterates: Buy | $36 | $21.86 | +64.66% | 2 | Aug 13, 2025 | |
| FEMY Femasys | Maintains: Buy | $12 → $8 | $0.61 | +1,206.12% | 25 | Aug 11, 2025 | |
| CNTX Context Therapeutics | Maintains: Buy | $5 → $4 | $1.40 | +185.71% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $2.29 | +293.01% | 2 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $27 | $26.79 | +0.78% | 2 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $2.40 | +733.33% | 10 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $6.65 | +441.35% | 9 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $86.80 | +32.49% | 13 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $12 | $2.81 | +327.05% | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $10.57 | +183.82% | 20 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $4.32 | +154.63% | 11 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $14.15 | +1,878.80% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.86 | +330.11% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $5.07 | +491.72% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.83 | +938.25% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $2.16 | +733.33% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $183 | $5.06 | +3,508.89% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.08 | +548.15% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.31 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $14.60 | +64.38% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $2.10 | +757.14% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.56 | - | 15 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $13.49 | +181.69% | 18 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $0.59 | +5,493.22% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.34 | - | 1 | Apr 25, 2024 |
TG Therapeutics
Oct 6, 2025
Assumes: Buy
Price Target: $60
Current: $33.76
Upside: +77.73%
AnaptysBio
Sep 30, 2025
Maintains: Buy
Price Target: $38 → $59
Current: $31.37
Upside: +88.08%
IO Biotech
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.55
Upside: -
Agenus
Sep 10, 2025
Reiterates: Buy
Price Target: $23
Current: $3.97
Upside: +479.35%
Agios Pharmaceuticals
Sep 4, 2025
Reiterates: Buy
Price Target: $56
Current: $40.61
Upside: +37.90%
BriaCell Therapeutics
Aug 27, 2025
Maintains: Buy
Price Target: $32 → $40
Current: $12.40
Upside: +222.58%
MiNK Therapeutics
Aug 15, 2025
Upgrades: Buy
Price Target: $35
Current: $14.00
Upside: +150.00%
vTv Therapeutics
Aug 13, 2025
Reiterates: Buy
Price Target: $36
Current: $21.86
Upside: +64.66%
Femasys
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $0.61
Upside: +1,206.12%
Context Therapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.40
Upside: +185.71%
Jul 22, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $2.29
Upside: +293.01%
Jul 10, 2025
Maintains: Buy
Price Target: $6 → $27
Current: $26.79
Upside: +0.78%
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $2.40
Upside: +733.33%
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $6.65
Upside: +441.35%
Jun 16, 2025
Reiterates: Buy
Price Target: $115
Current: $86.80
Upside: +32.49%
Jun 11, 2025
Assumes: Buy
Price Target: $12
Current: $2.81
Upside: +327.05%
Apr 28, 2025
Reiterates: Buy
Price Target: $30
Current: $10.57
Upside: +183.82%
Apr 24, 2025
Reiterates: Buy
Price Target: $11
Current: $4.32
Upside: +154.63%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $14.15
Upside: +1,878.80%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $1.86
Upside: +330.11%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $5.07
Upside: +491.72%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.83
Upside: +938.25%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $2.16
Upside: +733.33%
Mar 26, 2025
Reiterates: Buy
Price Target: $183
Current: $5.06
Upside: +3,508.89%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $1.08
Upside: +548.15%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.31
Upside: -
Feb 26, 2025
Upgrades: Buy
Price Target: $24
Current: $14.60
Upside: +64.38%
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $2.10
Upside: +757.14%
Jan 14, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.56
Upside: -
Jan 14, 2025
Reiterates: Buy
Price Target: $38
Current: $13.49
Upside: +181.69%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $0.59
Upside: +5,493.22%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $4.34
Upside: -